Diacomit (stiripentol) — Medica
Treatment-refractory seizures/epilepsy (Lennox-Gastaut syndrome, infantile spasms, tuberous sclerosis complex, Sturge-Weber syndrome, Doose syndrome, infection-related or anoxo-ischemic epilepsy syndromes, cortical malformation/dysplasia, epileptic encephalopathies associated with sodium channel mutations, epilepsy with myoclonic absences)
Initial criteria
- age ≥ 6 months and weight ≥ 7 kg
- Patient has tried at least two other antiseizure medications (e.g., valproic acid, lamotrigine, topiramate, clonazepam, Banzel [rufinamide], felbamate, clobazam, Fycompa [perampanel], vigabatrin, levetiracetam, zonisamide)
- Prescribed by or in consultation with a neurologist
Reauthorization criteria
- Patient is responding to therapy (e.g., reduced seizure severity, frequency, and/or duration) as determined by the prescriber
Approval duration
1 year